Browsing articles from "April, 2024"

Treatment of Corneal Abrasions

Dear Colleagues:

OMIC wishes to bring to your attention an important discussion regarding treatment of simple corneal abrasions with topical anesthetic.The American College of Emergency Physicians (ACEP) recently published guidelines regarding the treatment of simple corneal abrasions, in which it concluded that  “…for only simple corneal abrasions, as diagnosed and treated in accordance with the full protocol described herein, it appears safe to prescribe or otherwise provide a commercial topical anesthetic (i.e., proparacaine, tetracaine, oxybuprocaine) for use up to every 30 minutes as needed during the first 24 hours after presentation, as long as no more than 1.5 to 2 mL total (an expected 24-hour supply) is dispensed and any remainder is discarded after 24 hours.” [1]

In a response[2], the American Academy of Ophthalmology respectfully disagreed with the ACEP recommendations and conclusions, citing a lack of robust supporting data. It further noted that a 2023 Cochrane study on the use of topical anesthetics for corneal abrasion concluded that there was little evidence to predict the safety and efficacy of such treatment. In conclusion, the AAO opined that to insure patient safety, more rigorous scientific studies that include ophthalmologists are needed before guidelines can be issued.

You may wish to consider the following treatment guidelines presented in a February 2024 EyeNet Cornea Clinical Update article, “Topical Anesthetics: The Latest on Use for Corneal Abrasions,” which offers a “three As” mnemonic device when treating corneal abrasions in the emergency department[3]:

  • Alternatives: Ointments, such as erythromycin, should be a first-line choice for pain relief.
  • Amount: If anesthetic drops are used, patients should only be given enough drops to last 24 hours.
  • Appointment:  An outpatient follow-up appointment is crucial to ensure resolution.

 

We hope that this information will be helpful to you.

Sincerely,

Robert S. Gold
Chair, OMIC Board

Michael Tigani, MD
Chair, OMIC Risk Management Committee

Andrew Iwach, MD
OMIC Board Member
[1] Green SM, Tomaszewski C, Valente JH et al.  Use of Topical Anesthetics in the Management of Patients with Simple Corneal Abrasions:  Consensus Guidelines from the American College of Emergency Physicians. Ann Emerg Med. 2024; in press. DOI: https://doi.org/10.1016/j.annemergmed.2024.01.004.
[2]  Chuck S, Jeng B, Lum F. Consensus Guidelines versus Evidence-Based Medicine in the Treatment of  Corneal Abrasions. Ophthalmology. DOI: https://doi.org/10.1016/j.ophtha.2024.02.027. Epub ahead of print.
[3] Addis V, Fraunfelder F, Jacobs D, et al. Topical Anesthetics: The Latest on Use for Corneal Abrasions. EyeNet. February 2024, 29-31.

______________________________

Telephone Screening

April 8, 2024

Dear OMIC Insureds:

You rely on your staff to screen countless calls from patients each day. Having your employees ask patients the correct questions when they call to report a problem or seek advice will ensure calls are being handled appropriately. The materials in OMIC’s Telephone Screening Toolkit should be used as a guide to develop and implement a screening protocol for your practice. OMIC suggests the following recommendations to promote both the continuity and defensibility of telephone care:

  1. Exercise the same care when treating a patient over the telephone as you would during an office visit.
  2. Gather the information necessary to assess the situation and determine the treatment plan.
  3. Communicate the assessment and plan to the patient.
  4. Document the encounter and your decision-making process in the medical record.
  5. Develop written protocols for telephone screening and treatment that are specific to your patient population, subspecialty, and staff.
  6. Supervise staff members who screen calls. In addition to developing and approving written protocols, the supervision should include:
    1. Training and verification of competency.
    2. Answering questions from staff members unsure of how to handle specific calls.
    3. Regular review of how calls are handled and documented (e.g., patient complaint, type of appointment, staff advice, etc.), and
    4. periodic review of the screening protocols themselves.

If you have questions, contact us for confidential risk management advice at riskmanagement@omic.com or call us at 1-800-562-6642 and enter 4 for Risk Management.

Sincerely,

Amy Braswell
OMIC Risk Management Specialist




Six reasons OMIC is the best choice for ophthalmologists in America.

Supporting your specialty.

OMIC was founded by members of the American Academy of Ophthalmology nearly a quarter century ago and is the only carrier sponsored and endorsed by AAO. OMIC is also endorsed by 54 other ophthalmic societies. The OMIC partnerships with state and subspecialty societies qualifies their members for an exclusive 10% premium credit. Contact your state society for details.

61864684